Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 03:05 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
A Comparison of Oral Misoprostol and Vaginal Misoprostol for Cervical Ripening and Induction of Labor
NCT02777190 · Milton S. Hershey Medical Center · PHASE4 · terminated · last registry update 2022-10-13 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Insufficient research staff to recruit and complete study” | – | Registry record, Milton S. Hershey Medical Center |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against PTGER3 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2023-10-12Phase 3 first posted: Stanford University, Misoprostol 400mcg buccal + Placebo (NCT06078501)
- 2023-09-28Also stopped (withdrawn): Montefiore Medical Center, Misoprostol (NCT04768010)
- 2023-09-15Also stopped (suspended): Guangzhou Women and Children's Medical Center, Induction of labor with PGE2 (NCT04780269)
- 2023-09-07Results posted on the registry: Northwestern University, Misoprostol + Placebo (NCT02209545)
- 2023-09-07Also stopped (terminated): Northwestern University, Misoprostol + Placebo (NCT02209545)
- 2023-07-25Also stopped (terminated): Gynuity Health Projects, Mifepristone + 2 doses of misoprostol 800 mcg (NCT05119439)
- 2023-07-24Phase 3 first posted: Services Institute of Medical Sciences, Pakistan, Misoprostol Oral Tablet + vaginal misoprostol (NCT05957666)
- 2023-06-28Results posted on the registry: University of North Carolina, Chapel Hill, Ulipristal Acetate Tablets + Misoprostol Pill (NCT05216952)
- 2023-05-15Also stopped (terminated): University Hospital, Toulouse, Balloon catheter + oral misoprostol + Oral misoprostol alone (NCT03435458)
- 2023-05-03Phase 3 first posted: Planned Parenthood League of Massachusetts, Mifepristone plus one dose Misoprostol + Mifepristone plus two doses Misoprostol (NCT05839899)
- 2023-03-17Phase 3 first posted: Hospital Universitario 12 de Octubre, Vaginal dinoprostone (NCT05774236)
- 2023-03-09Phase 3 first posted: Beni-Suef University, Dinoprostone + Misoprostol (NCT05761418)
- 2023-01-23Results posted on the registry: Boston Medical Center, Methadone Pill + Ibuprofen (NCT04941443)
- 2023-01-23Also stopped (terminated): Boston Medical Center, Methadone Pill + Ibuprofen (NCT04941443)
- 2022-11-30Results posted on the registry: Vanderbilt University Medical Center, Misoprostol 100Mcg Tab (NCT03617172)
- 2022-11-30Also stopped (terminated): Vanderbilt University Medical Center, Misoprostol 100Mcg Tab (NCT03617172)
- 2022-11-14Also stopped (terminated): South Warwickshire NHS Foundation Trust, 10 mg Dinoprostone; CTS, UK + 3 mg Dinoprostone vaginal tablet; Pfizer, UK (NCT02956785)
- 2022-06-21Phase 3 first posted: Karolinska Institutet, Misoprostol (NCT05424445)
- 2022-03-31Phase 3 first posted: Calcutta National Medical College and Hospital, Mifepristone + Letrozole (NCT05304273)
- 2022-03-22Also stopped (withdrawn): University of Maryland, Baltimore, Misoprostol (NCT03796416)
- 2022-03-02Results posted on the registry: Medstar Health Research Institute, Mifepristone + Misoprostol (NCT02412618)
- 2022-02-17Phase 3 first posted: Stony Brook University, Sublingual Misoprostol + IV Oxytocin (NCT05245227)
- 2021-11-05Phase 3 first posted: Pak Emirates Military Hospital, Misoprostol (NCT05108597)
- 2021-11-01Results posted on the registry: Yuzuncu Yil University, Chlorhexidine Gluconate 0.12 % Mouthwash + benzydamine hydrochloride (NCT04373421)
- 2021-10-28Phase 3 first posted: Stanford University, Mifepristone + Misoprostol (NCT05097326)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision